Inoventive Bio Industries Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -41.42%
- Profit Growth -85.95%
- Ebitda 230.89%
- Net Worth 3.42%
- Total Assets 60.41%
About Inoventive Bio Industries
Inoventive Bio Industries Private Limited (IBIPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 December 2019 (Five years and two months 0 days old ). Its registered office is in Surat, Gujarat, India.
The Corporate was formerly known as Inoventive Bio Industires Private Limited. The Company is engaged in the Oil & Gas Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Neeraj Somani and Sudhakar Pandey serve as directors at the Company.
Company Details
-
Location
Surat, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U23209GJ2019PTC111184
-
Company No.
111184
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Dec 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Inoventive Bio Industries?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Somani
|
Director | 04-Dec-2019 | Current |
|
Sudhakar Pandey
|
Director | 04-Dec-2019 | Current |
Financial Performance of Inoventive Bio Industries.
Inoventive Bio Industries Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 41.42% decrease. The company also saw a substantial fall in profitability, with a 85.95% decrease in profit. The company's net worth moved up by a moderate rise of 3.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Inoventive Bio Industries?
Unlock access to Inoventive Bio Industries's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Nsr Chemicals Private LimitedNeeraj Somani is a mutual person
-
Aayu Polyplast Private Limited
Neeraj Somani is a mutual person
-
Newton Infratech Private Limited
Sudhakar Pandey is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Inoventive Bio Industries?
Unlock and access historical data on people associated with Inoventive Bio Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inoventive Bio Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inoventive Bio Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.